Summary The hypoxic cell radiosensitizer RSU 1069 (1-(2-nitro-1-imidazolyl)-3-(1-aziridinyl)-2-propanol) shows, on a concentration basis, a 100-fold greater toxicity towards hypoxic relative to aerobic cells. This toxicity is substantially greater than that of misonidazole, a compound of similar electron affinity. Reductive processes are important for hypoxic toxicity; this is demonstrated by the fact that misonidazole, in excess, can protect against the hypoxic but not aerobic toxicity of RSU 1069. The importance of the interaction of RSU 1069 with DNA, suggested initially by molecular studies, is supported by the fact that cells containing 5-bromodeoxyuridine (5-BUdR) incorporated into their DNA show greater sensitivity towards the lethal effects of RSU 1069 both in air and nitrogen, compared to cells not treated with 5-BUdR. Experiments with RSU 1069 and 3-aminobenzamide (3-AB) show the latter compound to potentiate aerobic toxicity, consistent with monofunctional alkylation by RSU 1069. In contrast, 3-AB has no effect on the hypoxic cytotoxicity of RSU 1069, which would be predicted if RSU 1069 is functioning as a bifunctional agent under these conditions. It is our contention that in air, RSU 1069 functions as a typical monofunctional alkylating agent, presumably due to the presence of the aziridine group whereas, in hypoxia, reduction of the nitro group provides an additional alkylating species, converting the compound into a bifunctional agent.
The compound RSU 1069 (NSC 347503), 1-(2-nitro-l-imidazolyl)-3-(1-aziridinyl)-2-propanol, has a similar one-electron reduction potential to that of misonidazole (Adams, 1984a) . However it is both much more efficient as a radiosensitizer and considerably more cytotoxic than misonidazole both in vitro and in vivo (Adams et al., 1984a,b) . Structurally RSU 1069 differs from misonidazole in that an aziridine replaces the methoxy group in the NI side-chain of the 2-nitroimidazole. Aziridines are monofunctional alkylating agents which can react with cellular macromolecules such as DNA (see e.g. Ross, 1962) and it has been recently shown that RSU 1069 and a product(s) of its reduction can bind to calf thymus DNA and cause single strand breaks in plasmid DNA (Silver et al., 1985) .
The aim of the present work was to characterize the cytotoxic effect of RSU 1069 at the cellular level. Results will be discussed with regard to those obtained in molecular studies (Silver et al., 1985; Silver & O'Neill, 1986) (Stratford & Adams, 1977) .
NAD assay Cellular NAD levels were determined using a method similar to that described by Jacobson & Jacobson (1976) . This is an NAD recycling assay, which depends upon the alcohol dehydrogenasecatalysed conversion of ethanol to acetaldehyde followed by reoxidation of the NADH via reaction between phenazine ethosulphate and MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide). The reaction leads to a progressive increase in optical density at 570 nm and the initial rate of increase is dependent upon the initial NAD concentration. The NAD extraction procedure was as follows. Following treatment, 2 x 106 cells were washed with Earle's balanced salt solution, treated with 0.5 M perchloric acid for 15 min on ice and sonicated (MSE Soniprep 150) at amplitude 1 for 20 sec (tip size, 9.5 mm). The supernatant fractions were adjusted to pH 7.5 by adding 1.5 ml of 1.095 mol dm -3 KOH in 0.33 mol dm 3 K2HPO4/KH2PO4 buffer and left on ice for a further 15min. Insoluble KC104 was then removed by centrifugation for 10min at 4°C and the supernatant stored frozen. NAD in the supernatant was assayed from the rate of change in optical absorption at 570 nm over 1 h using a kinetic analysis program on a Beckman Du8B UVvis spectrophotometer.
Glutathione assay
The method of Griffith (1980) was used for the extraction and determination of intracellular levels of glutathione as detailed previously by .
Compounds RSU 1069 was synthesized by Drs I. Ahmed and T.C. Jenkins in this Unit as described previously (Adams et al., 1984a) . All other compounds were purchased from Sigma (Poole, UK).
Results
The survival of cells taken from confluent cultures exposed to varying concentrations of RSU 1069 for 3 h in air or N2 is given in Figure 1 5mmdm-3 in air and N2 respectively (Stratford & Adams 1977; and unpublished data) .
An important feature in the toxicity of misonidazole, particularly under anaerobic conditions, is the ability of this compound to deplete cellular thiols (Biaglow, 1983) . In order to assess whether reduction of the total thiol level is contributing to the cytotoxic action of RSU 1069 we have measured cellular thiol concentrations before and after exposure to various concentrations of drug under aerobic and hypoxic conditions (Table I ). At the concentrations tested, many of which are supra-lethal (cf. Figure 1 ) there is no significant reduction of glutathione levels in both air and nitrogen. However, as total levels of oxidised and reduced glutathione were measured, (Griffith, 1980) , the possibility that RSU 1069 changes the ratio of reduced and oxidised glutathione cannot be ruled out. With this proviso, the data suggest that depletion of intracellular thiols is not the cause of the high cytotoxic efficiency of RSU 1069. However, it should be noted that misonidazole, under similar conditions of concentration and exposure time, does not deplete cellular thiols, but under these circumstances misonidazole is completely non-toxic.
Misonidazole and RSU 1069 are both 2-nitroimidazoles with similar electron affinities (Adams et al., 1976 (Adams et al., , 1984a . Reduction of the nitro group is a pre-requisite for the toxicity of misonidazole under hypoxic conditions (Adams et al., 1980) and similar processes are likely to operate for RSU 1069. One way of implicating reductive processes in RSU 1069 toxicity would be to inhibit the initial one-electron reduction step. A method of carrying out this inhibition under hypoxic conditions would be to incubate cells with RSU 1069 plus excess misonidazole. This would be feasible since there is a large difference in cytotoxic efficiency between RSU 1069 and misonidazole in N2. The compounds have similar reactivities with reducing agents and hence, would be expected to compete for reducing equivalents in proportion to the ratio of their concentrations. The establishment of the equilibrium will be RSU 1069 2.RSU 1069-MISO -MISO fast relative to the lifetimes for the decay of the radical anions (Clarke et al., 1984) . Thus if it is assumed that the intracellular lifetimes of the oneelectron reduced species of RSU 1069 and misonidazole (RSU 1069-and MISO'-respectively) are similar (Wardman, 1985; Silver et al., 1985) , then, with misonidazole in excess, reduction of RSU 1069 should be substantially inhibited. Figure 2 shows results of experiments where cells, in air or N2 have been exposed to various concentrations of RSU 1069 plus a 20-fold excess of misonidazole (95% of reducing equivalents should go to misonidazole). The maximum concentrations tested in N2 were 50/pmoldm 3 RSU 1069 and 1 mm dm3 misonidazole, and this concentration of misonidazole alone was non-toxic under these experimental conditions. In Figure 2 apparent that, under hypoxic conditions, misonidazole can partially protect cells from the cytotoxic effect of RSU 1069. However the protection factor is not equivalent to the 20-fold difference in concentration and this could be due to subtle differences in concentration at the site(s) where reduction takes place. Alternatively, it is possible that misonidazole could stimulate further reduction, giving more RSU 1069 -than would be predicted from their extracellular concentrations. However, for this to occur, it would depend on the nature of the nitroreductase system(s) involved in the one-electron reduction and whether the concentrations of the nitro compounds are sufficiently high to saturate these enzymes. Nevertheless, the results clearly demonstrate the importance of reduction in the hypoxic toxicity of RSU 1069. In contrast, in air, the excess misonidazole has no effect which indicates that the protective effect of 02 is maximal and reduction is playing no part in the aerobic toxicity of RSU 1069.
The structural difference between misonidazole and RSU 1069 is that the latter contains an aziridine group and it is likely that this moiety contributes significantly to the much greater cytotoxic efficiency of RSU 1069. It has been F _ shown previously (Silver et al., 1985; Silver & O'Neill, 1986 ) that RSU 1069 can interact with DNA via the aziridine and we have carried out some experiments which suggest that similar processes may also occur in cells. These experiments were of two types. Firstly, cells were labelled for 24h with 10,moldm-3 5-BUdR (5-bromodeoxyuridine) prior to treatment with RSU 1069. Such cells with 5-BUdR incorporated into their DNA, have previously been shown to be much more sensitive to the effect of agents where DNA is known to be the target e.g. radiation or alkylating agents (Djordjevic & Zybalski 1960 , Schindler et al., 1966 . Secondly, during and after cytotoxic treatment with RSU 1069 cells have been exposed to 3-aminobenzamide (3-AB). This compound can inhibit ADP-ribosyltransferase (ADPRT), a nuclear enzyme that plays a role in controlling the ligation step of the excision repair of damage to DNA including that caused by many mono-functional alkylating agents (Criessen & Shall 1982) . When combined with mono-functional drugs, 3-AB potentiates their cytotoxicity (Nduka et al., 1980) and this is accompanied by an inhibition of the NAD depletion consequent upon cytotoxic treatment (Skidmore et a!., 1979) . 5mmdm-3 3-AB during and after treatment with RSU 1069 are also more sensitive to the aziridinyl nitroimidazole. Neither the 5-BUdR labelling procedure, where appropriate precautions were taken to avoid photo-chemical effects (Ben-Hur & Elkind, 1972) nor the treatment with 3-AB alone, results in any cytotoxicity. Intracellular levels of NAD were also measured following cytotoxic treatments with RSU 1069 in air, with or without 3-AB. These are shown in Table II . A 1 h treatment of cells with 2mmdm-3 RSU 1069 in air causes substantial NAD depletion, which is inhibited by the concomitant addition of 3-AB. The results given above suggest that DNA interactions are important in the toxicity of RSU 1069 in air. These interactions almost certainly occur via the aziridine group, since, in similar experiments the toxicity of misonidazole is not increased (Stratford et al., unpublished data) . Experiments with hypoxic cells have also been carried out when these cells are labelled with 5-BUdR and Figure 4 shows results from a representative experiment for cells treated either with 50 imoldm 3 RSU 1069 or 5mmdm-3 misonidazole for varying periods of time. Incorporation of 5-BUdR into DNA does not change the hypoxic toxicity of misonidazole, whereas, the toxicity of RSU 1069 is increased. The data in Figure 4 also illustrate the large difference in the hypoxic cytotoxic efficiency between RSU 1069 and misonidazole.
The results of hypoxic experiments with RSU 1069 and 3-AB are given in Figure 5 . Clearly, in N2 3-AB does not potentiate the cytotoxicity of RSU 1069, and in fact it probably has a slight protective effect. These data, which contrast with the potentiation of the aerobic cytotoxicity of RSU 1069 by 3-AB suggest the modes of action of RSU 1069 in air and N2 to be quite different.
Comparison of the data for the toxicity of RSU 1069 alone towards exponentially growing cells ( Figure 5 ) and plateau phase cells (Figure 1) Previously it has been shown that RSU 1069 binds to calf thymus DNA (Silver et al., 1985) and (Smith et al., 1 unpublished data). 4 5 can produce single strand breaks in DNA (Silver et al., 1985 , Edwards et al., 1984 . Both these studies _dm3 RSU stress the importance of the aziridine group in RSU (Silver et al., 1985) . Results of the cellular experiments in N2 implicate the importance of reductive processes and the results with 5-BUdR labelled cells suggest DNA as a target. However, 3-AB does not potentiate the hypoxic toxicity of RSU 1069, which contrasts with its effect under aerobic conditions. The molecular results imply that under reducing conditions RSU 1069 can become a bifunctional agent and we have shown previously that 3-AB does not potentiate the cytotoxicity of bifunctional alkylating agents such 10-4 as melphalan (Walling et al., 1984 (Whitmore & Gulyas, 1986 ). This implies that RSU 1069 has bifunctional character under hypoxic conditions. In conclusion, experiments at the cellular and molecular level have provided evidence for the likely mechanism(s) operating in the cytotoxic actions of RSU 1069 under aerobic and hypoxic conditions. In air, RSU 1069 appears to act as a monofunctional alkylating agent, with the potential to act in a bifunctional manner under hypoxic, reducing conditions. However, it remains to be determined whether the reductive processes revealed here relate to the mechanism(s) of the increased hypoxic cell radiosensitizing efficiency of this compound seen both in cells in vitro and solid tumours in vivo (Adams et al., 1984a, b) .
